Key questions regarding the SYMPLICITY HTN-3 trial - Authors' reply

Lancet. 2023 Apr 22;401(10385):1337-1338. doi: 10.1016/S0140-6736(23)00337-9.

Authors

Deepak L Bhatt¹, George L Bakris²

Affiliations

¹ Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, NY 10029, USA. Electronic address: dlbhattmd@post.harvard.edu.
² Department of Medicine, University of Chicago, Chicago, IL, USA.

PMID: 37087166
DOI: 10.1016/S0140-6736(23)00337-9

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Hypertension* / surgery
Kidney
Sympathectomy